Clinical Trial Update: Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ? [Phase 3]

View source ↗

Summary

Phase 3 trial update noting completion of a study evaluating whether adding heparin to Taurolock-TM catheter lock solution improves catheter patency in hemodial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Heparin (unfractionated heparin)
• Taurolock-TM CLS (taurolock-tm catheter lock solution)

Snippet

Sponsor: Western Galilee Hospital-Nahariya | Conditions: End Stage Renal Disease, Hemodialysis | Phase 3 | Status: COMPLETED